loadpatents
Patent applications and USPTO patent grants for Kulagowski; Janusz Jozef.The latest application filed is for "new substituted azaindoline derivatives as nik inhibitors".
Patent | Date |
---|---|
Substituted azaindoline derivatives as NIK inhibitors Grant 11,236,084 - Hynd , et al. February 1, 2 | 2022-02-01 |
Cyanoindoline derivatives as NIK inhibitors Grant 11,186,589 - Stansfield , et al. November 30, 2 | 2021-11-30 |
Substituted cyanoindoline derivatives as NIK inhibitors Grant 11,180,487 - Stansfield , et al. November 23, 2 | 2021-11-23 |
Heteroaromatic derivatives as NIK inhibitors Grant 11,136,311 - Stansfield , et al. October 5, 2 | 2021-10-05 |
New Substituted Azaindoline Derivatives As Nik Inhibitors App 20210188840 - HYND; George ;   et al. | 2021-06-24 |
6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors Grant 11,001,569 - Stansfield , et al. May 11, 2 | 2021-05-11 |
New Substituted Cyanoindoline Derivatives As Nik Inhibitors App 20210087182 - STANSFIELD; Ian ;   et al. | 2021-03-25 |
Cyanoindoline Derivatives As Nik Inhibitors App 20210032267 - Stansfield; Ian ;   et al. | 2021-02-04 |
New 6-membered Heteroaromatic Substituted Cyanoindoline Derivatives As Nik Inhibitors App 20200109129 - STANSFIELD; Ian ;   et al. | 2020-04-09 |
Heteroaromatic Derivatives As Nik Inhibitors App 20190359598 - Stansfield; Ian ;   et al. | 2019-11-28 |
Cyanoindoline Derivatives As Nik Inhibitors App 20190119299 - Stansfield; Ian ;   et al. | 2019-04-25 |
Compounds as NIK inhibitors Grant 10,005,776 - Hynd , et al. June 26, 2 | 2018-06-26 |
1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors Grant 10,005,773 - Hynd , et al. June 26, 2 | 2018-06-26 |
Pyrazole derivatives as NIK inhibitors Grant 9,981,962 - Hynd , et al. May 29, 2 | 2018-05-29 |
3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors Grant 9,981,963 - Hynd , et al. May 29, 2 | 2018-05-29 |
New Compounds As Nik Inhibitors App 20170334906 - HYND; George ;   et al. | 2017-11-23 |
NEW 1-(4-PYRIMIDINYL)-1H-PYRROLO[3,2-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS App 20160257679 - HYND; George ;   et al. | 2016-09-08 |
NEW 3-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS App 20160229851 - HYND; George ;   et al. | 2016-08-11 |
Compounds Grant 9,023,855 - Blench , et al. May 5, 2 | 2015-05-05 |
Novel Compounds App 20140179714 - Blench; Toby Jonathan ;   et al. | 2014-06-26 |
Compounds Grant 8,691,826 - Blench , et al. April 8, 2 | 2014-04-08 |
Novel Compounds App 20130065913 - Blench; Toby Jonathan ;   et al. | 2013-03-14 |
Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase Grant 7,893,060 - Hancox , et al. February 22, 2 | 2011-02-22 |
Thiazolopyrimidines And Their Use As Inhibitors Of Phosphatidylinositol-3 Kinase App 20100190769 - Hancox; Timothy Colin ;   et al. | 2010-07-29 |
Piperidines and related compounds for treatment of alzheimer's disease Grant 7,638,629 - Hannam , et al. December 29, 2 | 2009-12-29 |
Tetrahydropyran compounds as tachykinin antagonists Grant 7,393,858 - Dirat , et al. July 1, 2 | 2008-07-01 |
Piperidines and Related Compounds for Treatment of Alzheimer's Disease App 20080021043 - Hannam; Joanne Clare ;   et al. | 2008-01-24 |
5-HT.sub.7 receptor antagonists Grant 7,276,607 - Curtis , et al. October 2, 2 | 2007-10-02 |
Sulfone derivatives as 5-HT7 receptor ligands Grant 7,101,892 - Bourrain , et al. September 5, 2 | 2006-09-05 |
Tetrahydropyran derivatives and their use as therapeutic agents App 20050261285 - Dirat, Olivier ;   et al. | 2005-11-24 |
Sulfone derivatives as 5-HT7 receptor ligands App 20040229864 - Bourrain, Sylvie ;   et al. | 2004-11-18 |
Azabicyclic ether derivatives and their use as therapeutic agents Grant 6,727,249 - Curtis , et al. April 27, 2 | 2004-04-27 |
Pentaaza-cyclopental[a]naphthalene derivatives as ligands for GABAa .alpha.5 receptors Grant 6,613,766 - Curtis , et al. September 2, 2 | 2003-09-02 |
Use of NK-1 receptor antagonists for treating major depressive disorders Grant 6,613,765 - Baker , et al. September 2, 2 | 2003-09-02 |
Amidine derivatives as selective antagonists of ndma receptors App 20030119871 - Curtis, Neil Roy ;   et al. | 2003-06-26 |
Azabicyclic ether derivatives and their use as therapeutic agents App 20020193402 - Curtis, Neil Roy ;   et al. | 2002-12-19 |
Azabicyclic Spiroether Derivatives And Their Use As Therapeutic Agents App 20020147207 - Huscroft, Ian Thomas ;   et al. | 2002-10-10 |
Spirocyclic ketones and their use as tachykinin antagonists Grant 6,372,754 - Kulagowski April 16, 2 | 2002-04-16 |
Spiro-azacyclic derivatives and their use as therapeutic agents Grant 6,172,077 - Curtis , et al. January 9, 2 | 2001-01-09 |
Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety Grant 6,114,315 - Baker , et al. September 5, 2 | 2000-09-05 |
Spiro-piperidine derivatives and their use as therapeutic agents Grant 6,071,928 - Curtis , et al. June 6, 2 | 2000-06-06 |
Spiro-piperidine derivatives and their use as therapeutic agents Grant 6,071,927 - Baker , et al. June 6, 2 | 2000-06-06 |
Antipsychotic benzimidazole derivatives Grant 5,792,768 - Kulagowski , et al. August 11, 1 | 1998-08-11 |
Antipsychotic indazole derivatives Grant 5,780,475 - Baker , et al. July 14, 1 | 1998-07-14 |
Benzimidazole derivatives Grant 5,714,498 - Kulagowski , et al. February 3, 1 | 1998-02-03 |
Pyrrolo-pyridine derivatives Grant 5,712,285 - Curtis , et al. January 27, 1 | 1998-01-27 |
Pyrrolo-pyridine derivatives Grant 5,700,809 - Leeson , et al. December 23, 1 | 1997-12-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.